Pharmacology & ToxicologybioRxiv
The Treatment of Clear Cell Ovarian Cancer with the Poly(ADP- Ribose) Polymerase (PARP1) Inhibitors (AG14361,Veliparib,Olaparib) as Chemosensitizers.
This study tests the effectiveness of PARP inhibitors as chemosensitizers for clear cell ovarian cancer, finding they enhance sensitivity to several chemotherapy agents.
DOI 10.15520/jcmro.v3i11.362